← Leaderboards
Daniel Calabrese
Veterans Affairs Med Ctr San Francisco
$301,840
Attributed
$301,840
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $301.8K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$301,840 · 1
VA$0 · 1
By mechanism
R34$301,840 · 1
IK2$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Veterans Affairs Med Ctr San Francisco
Same institution · by research overlap
- John Greenland$3,089,036
Others in their field
Other Emerging Leaders on “Lung Injury”
- Jennifer Cohen Price · University Of California, San Francisco$9,197,178
- Barry Hart · Innovation Pathways, Llc$8,985,162
- Elizabeth Ann Sugar · Johns Hopkins University$6,288,276
- Maurizio Franco Cereda · University Of Pennsylvania$4,916,519
- Giovanni Ligresti · Mayo Clinic Rochester$4,830,216
- Yogesh Saini · North Carolina State University Raleigh$4,705,067
Research focus
Lung InjurySamplingFunctional DisorderLung AllograftPhenotypeReperfusion InjuryClinical TrialsFoundationsInjuryLungMouse ModelNatural Killer CellsAllograftingChemokine ReceptorCcr5 GeneCellsCytokineFlow CytometryFutureImmuneInnate Immune ResponseLigandsLung TransplantationTissues
Grant awards (5)
EPIC-LT: Eliminating PGD through Inhibition of CCR5 in Lung Transplantation$301,840
R34 · FY2025 · HL · contact PI
Natural killer cells in pulmonary ischemia-reperfusion injury$0
IK2 · FY2024 · VA · contact PI
Natural killer cells in pulmonary ischemia-reperfusion injury$0
IK2 · FY2023 · VA · contact PI
Natural killer cells in pulmonary ischemia-reperfusion injury$0
IK2 · FY2022 · VA · contact PI
Natural killer cells in pulmonary ischemia-reperfusion injury$0
IK2 · FY2021 · VA · contact PI